Oct 2026· Gynecologic Oncology· Vol 214, pp.
43-58
· 0 citations· 101 references
Medicine
Abstract
Background
Uterine sarcomas (US) account for 3-7% of uterine malignancies but cause disproportionate high cancer-related mortality. Despite expanding molecular profiling, evidence remains fragmented across histological categories, limiting translation into validated prognostic tools and actionable therapeutic targets.
Methods
We conducted a comprehensive review, searching MEDLINE, Scopus, Web of Science, and ProQuest. Eligible studies were systematic or high-quality narrative reviews evaluating molecular biomarkers with diagnostic, prognostic, or predictive relevance in US. Methodological quality was assessed using AMSTAR-2 and SANRA, and pooled prevalence estimates derived using random-effects models, complemented by publicly available genomic dataset analysis.
Results
Twenty-nine reviews met inclusion criteria, encompassing leiomyosarcoma (LMS), endometrial stromal sarcoma (ESS), adenosarcoma, perivascular epithelioid cell tumor (PEComa), and uterine tumor resembling ovarian sex cord tumor; after de-duplication, they contributed 71 distinct primary studies comprising 1812 unique patients. Thirty-seven molecular biomarkers with potential clinical relevance were identified. In ESS, grade-stratified analysis separated the two entities sharply: hormone receptor estrogen (ER) and progesteron (PR) were expressed in 82% and 92% of low-grade ESS (LG-ESS) versus 38% and 47% of high-grade ESS (HG-ESS) (between-stratum p < 0.001 and p = 0.002) defining a hormone-responsive, therapeutically actionable profile in LG disease. HG-ESS was characterized by Cyclin D1 overexpression (68%) and by YWHAE-NUTM2A/B (42%) and ZC3H7B-BCOR rearrangements (36%) rearrangements. LMS was characterized by TP53 (68%) and RB1 (48%) co-inactivation. PEComa demonstrated mTOR pathway activation (MelanA 79%), consistent with established mTOR inhibitor sensitivity. High clinical actionability (ESCAT tiers I-II) was confined to rare kinase fusions, while most biomarkers remained at lower evidence levels.
Conclusions
Molecular profiling is essential for histotype classification in US and increasingly informative for prognostic stratification, yet predictive utility remains largely confined to a subset of tumor types. Prospective biomarker-driven trials are needed to bridge the persistent gap between biological discovery and clinical implementation.
It is found that Llama 3 delivers comparable quality to leading language models such as GPT-4 on a plethora of tasks, and performs competitively with the state-of-the-art on image, video, and speech recognition tasks.
This publication proposes a definition and a classification of agile software development approaches and analyses ten software development methods that can be characterized as being "agile" against the defined criterion.
P. Abrahamsson, O. Salo, Jussi Ronkainen et al.· arXiv.org· 727 citations· ⚡54
The study shows that agile practices improve both informal and formal communication, but indicates that, in larger development situations involving multiple external stakeholders, a mismatch of adequate communication mechanisms can sometimes even hinder the communication.
M. Pikkarainen, Jukka Haikara, O. Salo et al.· Empirical Software Engineeri...· 401 citations· ⚡48
The results indicate that software engineering work practices are chosen opportunistically, adapted and configured to provide value under the constrains imposed by the startup context.
Nicolò Paternoster, Carmine Giardino, M. Unterkalmsteiner et al.· Information and Software Tec...· 394 citations· ⚡54
It is proved that any global minimizer of the trajectory balance objective can define a policy that samples exactly from the target distribution, and empirically demonstrate the benefits of the trajectories balance objective for GFlowNet convergence, diversity of generated samples, and robustness to long action sequenc...
Esmeralda S. Whitammer, Moksh Jain, Emmanuel Bengio et al.· Neural Information Processin...· 302 citations· ⚡60